Table 2 Comparison of age and PSA levels in the incidental prostate cancer and benign prostatic hyperplasia groups
Variables | IPC group | BPH group | Total | p |
|---|---|---|---|---|
n (%) | n (%) | n (%) | ||
Age (years) | 0.0001 | |||
≤ 59 | 7 (5.4%) | 122 (94.6%) | 129 (14.3%) | |
60–69 | 44 (12.4%) | 312 (87.6%) | 356 (39.6%) | |
70–79 | 45 (14.1%) | 274 (85.9%) | 319 (35.4%) | |
≥ 80 | 24 (25.0%) | 72 (75.0%) | 96 (10.7%) | |
PSA (ng/mL) | 0.019 | |||
0.00–0.99 | 16 (8.1%) | 182 (91.9%) | 198 (22.0%) | |
1.00–2.49 | 43 (15.1%) | 241 (84.9%) | 284 (31.6%) | |
2.50–3.99 | 15 (10.8%) | 124 (89.2%) | 139 (15.4%) | |
4.00–9.99 | 32 (14.6%) | 187 (85.4%) | 219 (24.3%) | |
≥ 10.00 | 14 (23.3%) | 46 (76.7%) | 60 (6.7%) | |
Total | 120 (13.3%) | 780 (86.7%) | 900 (100.0%) |